Neurocrine Biosciences is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.
Neurocrine Biosciences is a publicly traded company on using the ticker symbol NBIX.
Detailed information on company financials and operating reports can be found here:
: NBIX
Neurocrine Biosciences Annual Revenue and Growth Rate
Note: Neurocrine Biosciences's revenues are gauged from an analysis of company filings.
Trademark Applications
Trademark applications show the products and services that Neurocrine Biosciences is developing and marketing.
Neurocrine Biosciences doesn't have any recent trademark applications, indicating Neurocrine Biosciences is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
CANECT-HD Providing medical information to patients, medical professionals, and insurance companies in the field of Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders; Online information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders; Providing pharmaceutical consultancy services
01/19/2024
SAVITRI Providing medical information; providing medical information relating to therapies and treatments for major depressive disorder and neurological, central nervous system, psychiatric, and mood disorders
10/05/2023
TD-KINECTION Providing medical information; providing medical information relating to therapies and treatments for neurological, central nervous system, and movement diseases and disorders and tardive dyskinesia
09/21/2023
See all trademarks and details in the Full Report.
Market Share of Neurocrine Biosciences's Largest Competitors
A competitive analysis shows these companies are in the same general field as Neurocrine Biosciences, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Neurocrine Biosciences.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Neurocrine Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.